Parent Drug and Active Metabolite (FDA) [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2006-05-10 10:22 (6647 d 01:43 ago) – Posting: # 123
Views: 8,392

❝ […] would this mean that ANOVA on the metabolite data is not necessary?

Hi Joy,

yes, IMHO no confidence interval of the metabolite; you should present just means, standard deviations, etc. If you opt to present a confidence interval make clear in the protocol, that there's no acceptance range for it.

The wonderful thing about FDA is that you have to present the study protocol to them anyhow; if they don't like it, they will tell you ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
23,112 posts in 4,858 threads, 1,644 registered users;
58 visitors (0 registered, 58 guests [including 10 identified bots]).
Forum time: 12:05 CEST (Europe/Vienna)

It’s always fun to have your models validated,
but is way more fun to have them trashed.
Finding out you are completely wrong
is a great part of science.    G. Randall Gladstone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz